Article
Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions
26 Feb 2020
Abstract excerpt
Temozolomide (TMZ) is a drug of choice in glioblastoma treatment. Its therapeutic applications expand also beyond high grade gliomas. However, a significant number of recurrences and resistance to the drug is observed. The key factor in each chemotherapy is to achieve the therapeutic doses of a drug at the pathologic site. Nonetheless, the rate of temozolomide penetration from blood to cerebrospinal fluid is only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
